HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of pseudomembranous colitis associated with rifampicin therapy in a patient with rectal cancer and gastrointestinal tuberculosis].

Abstract
Pseudomembranous colitis (PMC) is known to be associated with the administration of antibiotics which alter normal gastrointestinal flora and allow overgrowth of Clostridium difficile. Most cases of rifampicin-induced PMC are seen in patients with pulmonary tuberculosis, but not with gastrointestinal tuberculosis. We report a case of PMC associated with rifampicin therapy in a patient with gastrointestinal tuberculosis. A 65-year-old female patient with rectal cancer and gastrointestinal tuberculosis was admitted due to abdominal pain and diarrhea. She was treated with anti-tuberculosis agents containing rifampicin. On colonoscopic examination, mucoid exudates and yellowish plaque lesions were observed. Anti-tuberculosis agents were stopped, and the patient was treated with metronidazole. Symptoms were relieved and did not recur when all the anti-tuberculosis agents except rifampicin were started again. When a patient complains of abdominal pain or diarrhea while taking rifampicin, the physician should consider the possibility of rifampicin-associated PMC.
AuthorsYong Jun Choi, Hyung Gil Kim, Yun Ah Choi, Woo Chul Joo, Dong Wook Son, Chul Hyun Kim, Yong Woon Shin, Young Soo Kim
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol) Vol. 53 Issue 1 Pg. 53-6 (Jan 2009) ISSN: 1598-9992 [Print] Korea (South)
PMID19158472 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibiotics, Antitubercular
  • Rifampin
Topics
  • Aged
  • Antibiotics, Antitubercular (adverse effects, therapeutic use)
  • Enterocolitis, Pseudomembranous (diagnosis, etiology, pathology)
  • Female
  • Humans
  • Rectal Neoplasms (complications, diagnosis)
  • Rifampin (adverse effects, therapeutic use)
  • Sigmoidoscopy
  • Tuberculosis, Gastrointestinal (complications, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: